Publication:
Acute kidney injury from SGLT2 inhibitors: Potential mechanisms

Simple item page
dc.contributor.coauthorHahn, Kai
dc.contributor.coauthorEjaz, A. Ahsan
dc.contributor.coauthorLanaspa, Miguel A.
dc.contributor.coauthorJohnson, Richard J.
dc.contributor.departmentN/A
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid110580
dc.date.accessioned2024-11-09T23:36:10Z
dc.date.issued2016
dc.description.abstractSGLT2 inhibitors have shown great promise in the management of diabetes mellitus and the prevention of cardiovascular complications, but increasing evidence suggests that their use can be associated with an increased risk of acute kidney injury. Insights into the mechanisms involved might help to identify individuals who are at risk of renal injury.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume12
dc.identifier.doi10.1038/nrneph.2016.159
dc.identifier.eissn1759-507X
dc.identifier.issn1759-5061
dc.identifier.scopus2-s2.0-84995678272
dc.identifier.urihttp://dx.doi.org/10.1038/nrneph.2016.159
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12606
dc.identifier.wos388729400001
dc.keywordsN/A
dc.languageEnglish
dc.publisherNature Portfolio
dc.sourceNature Reviews Nephrology
dc.subjectUrology
dc.subjectNephrology
dc.titleAcute kidney injury from SGLT2 inhibitors: Potential mechanisms
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.authorid0000-0002-1297-0675
local.contributor.kuauthorKanbay, Mehmet

Files

Collections

Publications without Fulltext